Jun Lei
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 8
-
- Cancer-related molecular mechanisms research 5
Jun Lei
50 papers receiving 981 citations
Peers
Comparison fields: 5 of 100
- Hepatology 168
- Cancer Research 233
- Oncology 240
- Pulmonary and Respiratory Medicine 230
- Molecular Biology 472
Countries citing papers authored by Jun Lei
This map shows the geographic impact of Jun Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Lei more than expected).
Fields of papers citing papers by Jun Lei
This network shows the impact of papers produced by Jun Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Lei. The network helps show where Jun Lei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jun Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2022 | 3 | |
| 4 | 2022 | 8 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 7 | |
| 7 | 2020 | 20 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 30 | |
| 10 | 2018 | 13 | |
| 11 | 2018 | 22 | |
| 12 | 2016 | 61 | |
| 13 | 2016 | 17 | |
| 14 | 2015 | 7 | |
| 15 | 2015 | 23 | |
| 16 | 2015 | 1 | |
| 17 | 2014 | 99 | |
| 18 | HDAC inhibitors suppressed small cell lung cancer cell growth and enhanced the suppressive effects of receptor-targeting cytotoxins via upregulating somatostatin receptor II. | 2012 | 27 |
| 19 | 2008 | 8 | |
| 20 | 1993 | 12 |
About Jun Lei
Jun Lei is a scholar working on Hepatology, Cancer Research, Pulmonary and Respiratory Medicine, Surgery and Oncology, having authored 51 papers that have together received 991 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Ubiquitin and proteasome pathways (7 papers), Gallbladder and Bile Duct Disorders (7 papers), Cancer-related molecular mechanisms research (5 papers), Cancer-related gene regulation (5 papers), Cancer Mechanisms and Therapy (5 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Hepatology (168 citations), Cancer Research (233 citations), Oncology (240 citations), Pulmonary and Respiratory Medicine (230 citations) and Molecular Biology (472 citations). Jun Lei has collaborated with scholars based in China, United States and Cyprus. Frequent co-authors include Jianghua Shao, Rongfa Yuan, Xiuxia Liu, Linquan Wu, Ge Jin, Xin Yu, Wenxiong Zhang, Junwen Hu, Leifeng Chen and Yan Chen. Their work appears in journals such as Surgical Endoscopy, Scientific Reports, Oncotarget, BMC Surgery and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.